Market Tracker

09/02 6:01pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

During the Trading Day
9.24 +0.98 / +11.86%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
9.30 +0.06 / +0.65%
 
Volume: 29.4K
No recent news for Regulus Therapeutics Inc.

Today’s Trading

Previous close8.26
Today’s open8.40
Day’s range8.23 - 9.25
Volume1,074,790
Average volume (3 months)807,591
Market cap$428.9M
Dividend yield--
Data as of 3:59pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)-4.81%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book3.06

Competitors

 Today’s
change
Today’s
% change
ADXSAdvaxis Inc+0.10+0.73%
PRTKParatek Pharmaceutic...+0.50+2.04%
IGIGI Laboratories Inc+0.23+2.86%
INFIInfinity Pharmaceuti...+0.41+4.77%
Data as of 4:05pm ET, 09/02/2015

Financials

Next reporting dateNovember 4, 2015
EPS forecast (this quarter)-$0.37
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
CFO, Secretary, CAO &
General Counsel
David L. Szekeres
Corporate headquarters
San Diego, California

Forecasts